In our studies, treatment with TG did result in the differentiation of the As3+-transformed cells based upon morphological changes and induced the expression of PPARγ as well as FOXA1 both of which are factors known to drive luminal differentiation of bladder cancer cell lines. The gene discussed is PPARG; the disease is urinary bladder cancer.